IMV Inc IMVIF

Anybody speak with management lately?

[Lambom]

Pretty quiet here lately!. What are they up to? Are they actually progressing on covid? Or smoke and mirrors.

[Hideaway]

Lambon,I've tried reaching investor relations several times the past but always go to voice mail.Don't really think it would provide me with anything except more excuses as to why they are not progressing more rapidly and say they are on schedule as detailed in the last timeline chart.Of course these dates were extended from the expectations presented a few months previous.It would not

[Biotech010]

spoke with the company, HC is causing the delays on the Covid front. dlbcl is the fastest path to market. Insiders BOUGHT at higher prices, extremely dissapointed with SP.

[TexasTea20]

Curious who you spoke with. Did the person say specifically what was causing the delays with HC?  For the record..... WE ALL BOUGHT AT HIGHER PRICES!!!! Ors getting nuked or resigning is probaly worth a doulbe or triple from here seconds after the announcement. Clearly he is out of his league protected by a Chairman who has been with him for many years while also somehow maintaining a board

[Hideaway]

Texas,Think most longs would agree with you,Can't believe they are insinuating HC is still the culprit.I'm sure the bureaucracy is slow but if the data they get from IMV is timely and complete and as great as they claim,it seems unlikely HC is to blame.

[TexasTea20]

One has to wonder how much work IMV did in determining what would be required and what HC wanted to see from the beginning. What has been insituated is that they are dealing with a moving target in terms of the regulatory regime. I understand that this is not your typical mRNA or other type of vaccine and is a new concept for regulators and all... but man this is pathetic. Its not as if the

[Jthom376]

Who knows really about HC.... there has been an uptick in trials over the last few weeks. Maybe we get lucky. I do not believe IMV are forthcoming. Im just waiting for clinicals... believe they are to publish in q2. If nothing results, win some lose some... move on 

[Lambom]

I look on the health Canada website and see no mention of Imv or an application (status) on covid. I see many others listed with there status. What's really going on here.  Imv needs someone more suited to the position to get things rolling. 

[Jthom376]

I think we will know where it all stands once clinicals are published. That 2nd round of funding they received from Canada - circa 5 mill... was based on milestones. During the March Q4 financials, that funding showed around 50k being used... so by the end of Q4 they'd done next to nothing to trigger payout. That was how I read it....

[qwerty22]

What months did that Q cover? Initially the preclinical work is relatively cheap. It probably only starts to scale up when you do manufacturing, toxicology and animal challenge studies. If those things happened then my guess is in late 2020 before the more expensive stuff begins to kick in. Obviously it really scales up once human studies start, they aren't there though.  

[Jthom376]

It was their fiscal 2020 financial report. So thru December 31 2020. I do believe they are being held up... otherwise they'd be foolish not to continue collecting free money. Maybe I'm wrong but it seems that grant is still waiting to be collected.....  In October 2020, the Corporation qualified for an additional $5.4 million in project funding from NRC IRAP, to support the